Federal Reserve Chair Jerome Powell (Alex Brandon/AP Images)
September 18, 2024 02:07 PM EDTUpdated 02:55 PM
Pharma

Here's what to­day's Fed rate cut means for biotech, phar­ma and ven­ture cap­i­tal

Max Gelman

Senior Editor

The Fed­er­al Re­serve made its long-an­tic­i­pat­ed in­ter­est rate cuts on Wednes­day, low­er­ing rates by a half of a per­cent­age point.

It’s the first time the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Edge­wise’s stock surges as heart drug pass­es ear­ly safe­ty test

Ex­clu­sive: Flag­ship-backed Va­lo Health los­es in­ter­im CEO ahead of key Phase 2 read­out

Stem cell start­up spun out of George Church’s lab rais­es $75M

FDA in­spec­tors dis­cov­er trucks car­ry­ing torn-up records leav­ing In­di­an gener­ics fac­to­ry

Roche out­lines com­mer­cial man­u­fac­tur­ing strat­e­gy for GLP-1/GIP as­sets 

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times